FDA issues guidance on using certain dry heat systems to support respirator reuse
![FDA-guidance](/sites/default/files/styles/900x400/public/2018-07/FDA-guidance.jpg?itok=I8jaZmAO)
The Food and Drug Administration last week released enforcement policy guidance for health care providers and others using dry heat systems to reduce bioburden on certain N95 and other respirators in limited supply to support reuse by health care personnel during the COVID-19 public health emergency.
FDA has not issued any emergency use authorizations for such systems, but said it does not intend to object to using them to support single-user reuse of certain otherwise disposable filtering facepiece respirators during the emergency.
System manufacturers should follow both the FDA enforcement guidance and the Centers for Disease Control and Prevention’s existing reuse recommendations, FDA said.
Related News Articles
Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…
Headline
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…